Total Funding
28
74
Total FundingPre-Seed raised
Growth Score
-30 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
127139
Bloonics is a biotech company utilizing innovative methods to measure cannabis impairment.
- Daniel Cohen: CEO and Co-Founder
Lex Beresnev: Co-founder, CTO & Marketing
About the Company
Bloonics is a biotech company utilizing innovative methods to measure cannabis impairment. It provides customizable tooling for clients, designed to adapt to any regulatory framework for drug enforcement today with an eye toward tomorrow.
The company aims to launch the toxicology assay for detecting active THC in saliva. The synthetic biology
behind its proprietary assay is the product of a 4-year ongoing collaboration with KU-Leuven and VIB, aimed at transforming active-dry yeast cells into functional diagnostics.
